Izrael - hebrejština - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine

Izrael - hebrejština - Ministry of Health

comex ltd - ivermectin - תמיסה להזרקה - ivermectin 10 mg/ml

Izrael - hebrejština - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine

Izrael - hebrejština - Ministry of Health

novartis israel ltd - brolucizumab - תמיסה להזרקה - brolucizumab 120 mg / 1 ml - brolucizumab

Izrael - hebrejština - Ministry of Health

j-c health care ltd - emtricitabine; rilpivirine as hydrochloride; tenofovir alafenamide as fumarate - טבליות מצופות פילם - tenofovir alafenamide as fumarate 25 mg; emtricitabine 200 mg; rilpivirine as hydrochloride 25 mg - rilpivirine

Izrael - hebrejština - Ministry of Health

j-c health care ltd - emtricitabine; rilpivirine as hydrochloride; tenofovir alafenamide as fumarate - טבליות מצופות פילם - tenofovir alafenamide as fumarate 25 mg; emtricitabine 200 mg; rilpivirine as hydrochloride 25 mg - rilpivirine

Izrael - hebrejština - Ministry of Health

zoetis israel holding b.v., israel - doramectin - תמיסה להזרקה - doramectin 10 mg/ml

Izrael - hebrejština - Ministry of Health

glaxo smith kline (israel) ltd - cabotegravir as sodium - טבליות מצופות פילם - cabotegravir as sodium 30 mg

Izrael - hebrejština - Ministry of Health

j-c health care ltd - rilpivirine - rilpivirine 300 mg / 1 ml - rilpivirine

Izrael - hebrejština - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.